课题基金 / 基金详情

项目摘要

项目成果

MARK HANNINK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A diverse and well-trained scientific workforce is necessary to advance biomedical research, improve human health and to develop effective remedies for disease. The University of Missouri-Columbia (MU) is the only four-year comprehensive public university in the State of Missouri and has a critical role in training the next generation of scientists. As part of the University of Missouri-Columbia (MU) commitment to scientific training and diversity, and with prior funding from NIH, we have developed a successful and innovative program to prepare underrepresented minority students for biomedical research. We have three objectives for our Initiative to Maximize Student Diversity (IMSD) program. First, to further develop a supportive and engaged peer community of minority undergraduate students that are interested in exploring biomedical research. We will increase the number of MU freshmen/sophomore students who are exploring a career in biomedical research. Second, we will expand a program targeted at MU junior/senior students that involves these advanced undergraduates in independent research experiences and prepares them for graduate study in the biomedical sciences. Third, we will provide a structured and mentored research environment for minority graduate students to develop into independent scientists as they pursue their PhD degree in a biomedical discipline. Further development of our IMSD program will have a substantial impact on diversity at the University and on our nation's scientific workforce.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMSD: An Initiative to Maximize Student Development in Biomedical Research at MU
  • 批准号:
    10333313
  • 项目类别:
  • 资助金额:
    $53.67万
  • 财政年份:
    2020
  • 负责人:
    MARK HANNINK
  • 依托单位:
IMSD: An Initiative to Maximize Student Development in Biomedical Research at MU
  • 批准号:
    10093103
  • 项目类别:
  • 资助金额:
    $50.61万
  • 财政年份:
    2020
  • 负责人:
    MARK HANNINK
  • 依托单位:
Role of a Novel E3-Ubiquitin Ligase in Chemoprevention
  • 批准号:
    7846963
  • 项目类别:
  • 资助金额:
    $53.58万
  • 财政年份:
    2009
  • 负责人:
    MARK HANNINK
  • 依托单位:
Molecular Basis of Gene Expression and Signal Processing
  • 批准号:
    7890788
  • 项目类别:
  • 资助金额:
    $6.42万
  • 财政年份:
    2009
  • 负责人:
    MARK HANNINK
  • 依托单位:
海外基金